Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0928-0987(00)00117-2PMID 11113639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications

  2002cited by this paper
• Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.

  2001cited by this paper
• Adult T‐cell leukemia cells over‐express the multidrug‐resistance‐protein (MRP) and lung‐resistance‐protein (LRP) genes

  1999cited by this paper
• Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.

  1999cited by this paper
• Epithelial Transport of Anthelmintic Ivermectin in a Novel Model of Isolated Proximal Kidney Tubules

  1999cited by this paper
• Tissue and Cell Distribution of the Multidrug Resistance-Associated Protein (MRP) in Mouse Intestine and Kidney

  1999cited by this paper
• Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein.

  1998cited by this paper
• Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line.

  1998cited by this paper
• A general pattern for substrate recognition by P-glycoprotein.

  1998cited by this paper
• ABC transporters : biochemical, cellular, and molecular aspects

  1998cited by this paper
• Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells.

  1998cited by this paper
• Radioligand-Binding Assay Employing P-Glycoprotein-Overexpressing Cells: Testing Drug Affinities to the Secretory Intestinal Multidrug Transporter

  1998cited by this paper
• Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.

  1998cited by this paper
• ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2.

  1998cited by this paper
• Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP.

  1997cited by this paper
• Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.

  1997cited by this paper
• Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells

  1997cited by this paper
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

  1997cited by this paper
• Induction of cMrp/cMoat gene expression by cisplatin, 2‐ acetylaminofluorene, or cycloheximide in rat hepatocytes

  1997cited by this paper
• Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.

  1996cited by this paper
• Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.

  1996cited by this paper
• Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cells

  1996cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• Active Secretion of Drugs from the Small Intestinal Epithelium in Rats by P‐Glycoprotein Functioning as an Absorption Barrier

  1996cited by this paper
• Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco‐2) cells

  1996cited by this paper
• On the relationship between the probenecid‐sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance‐associated protein (MRP)

  1995cited by this paper
• Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.

  1994cited by this paper
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

  1994cited by this paper
• Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.

  1994cited by this paper
• Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833.

  1994cited by this paper
• Structure and function of P-glycoprotein in normal liver and small intestine.

  1993cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper

• Functional Characterization of the Cat and Dog Wild-Type and Mutant MDR1 Carrier Proteins and Frequency of the MDR1 Gene Mutation in 800 Cats From Germany.

  2025cites this paper
• Comparison of Human and Canine P‐Glycoprotein Substrates at R, P, and H Binding Sites

  2025cites this paper
• Phytochemical-Mediated Modulation of Doramectin Pharmacology in Sheep: Exploring the Cinnamaldehyde–Pink Grapefruit Combination

  2025influential citation
• Differential UVC radiation sensitivity in multidrug-resistant l1210 cells: Insights into p53 and Bcl-XL expression/function.

  2025cites this paper
• Zosuquidar: An Effective Molecule for Intracellular Ca2+ Measurement in P-gp Positive Cells

  2024cites this paper
• A Quantitative Approach for Assessing Multidrug Resistance in Cancer

  2024cites this paper
• Combined in silico and in vitro approaches to identify P‐glycoprotein‐inhibiting pesticides

  2023cites this paper
• Comparative cytotoxicity, endocrine-disrupting effects, oxidative stress of halophenolic disinfection byproducts and the underlying molecular mechanisms revealed by transcriptome analysis.

  2022cites this paper
• Toward Xeno-Free Differentiation of Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells

  2022cites this paper
• In vitro effects of European and Latin-American medicinal plants in CYP3A4 gene expression, glutathione levels, and P-glycoprotein activity

  2022influential citation
• Disruption of small molecule transporter systems by Transporter‐Interfering Chemicals (TICs)

  2020influential citation
• Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications.

  2019cites this paper
• Development of a novel in vitro 3D intestinal model for permeability evaluations

  2019cites this paper
• Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter

  2018cites this paper
• Triorganotin Derivatives Induce Cell Death Effects on L1210 Leukemia Cells at Submicromolar Concentrations Independently of P-glycoprotein Expression

  2018cites this paper
• Role of P-glycoprotein in deoxynivalenol-mediated in vitro toxicity.

  2018cites this paper
• Toxicokinetics and toxicodynamics of chlorpyrifos is altered in embryos of Japanese medaka exposed to oil sands process‐affected water: evidence for inhibition of P‐glycoprotein

  2017cites this paper
• In vitro modulation of the cytochrome P450 and ABCB1/P-glycoprotein activities of the aqueous extract of Allophylus cominia (L) Sw. leaves

  2017cites this paper
• Multiparametric luminescent cell viability assay in toxicology models: A critical evaluation.

  2016cites this paper
• Identification and functional characterization of an ABC transporter of Haemonchus contortus, the P-glycoprotein 13

  2016cites this paper
• Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1).

  2016cites this paper
• In vitro Effects of Four Native Brazilian Medicinal Plants in CYP3A4 mRNA Gene Expression, Glutathione Levels, and P-Glycoprotein Activity

  2016cites this paper
• Haemonchus contortus P-glycoprotein-2: in situ localisation and characterisation of macrocyclic lactone transport.

  2015cites this paper
• Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure.

  2015cites this paper
• Effects of silver nanoparticles and ions and interactions with first line of defense

  2015influential citation
• Cell-Free Microfluidic Determination of P-glycoprotein Interactions with Substrates and Inhibitors

  2014cites this paper
• Inhibition of P-glycoprotein in the blood-brain barrier alters avermectin neurotoxicity and swimming performance in rainbow trout.

  2014cites this paper
• A novel concentration dependent amino acid ion pair strategy to mediate drug permeation using indomethacin as a model insoluble drug.

  2014cites this paper
• P‐gp efflux pump inhibition potential of common environmental contaminants determined in vitro

  2014cites this paper
• Re-evaluation of the role of P-glycoprotein in in vitro drug permeability studies with the bovine brain microvessel endothelial cells

  2014cites this paper
• Vincristine-induced expression of P-glycoprotein in MOLM-13 and SKM-1 acute myeloid leukemia cell lines is associated with coexpression of nestin transcript.

  2014cites this paper
• The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line

  2013cites this paper
• In vitro cell models in predicting blood-brain barrier permeability of drugs

  2013cites this paper
• Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS).

  2013cites this paper
• Transporter study methodologies

  2013cites this paper
• Amino acids in oral drug delivery:salts, ion-pairs and transcriptomics

  2013cites this paper
• Alkamides from Echinacea angustifolia Interact with P-Glycoprotein of Primary Brain Capillary Endothelial Cells Isolated from Porcine Brain Blood Vessels

  2013cites this paper
• Automatable microplate-based in vitro assays for screening intestinal drug transport and metabolism

  2012cites this paper
• Clinical Response and Side Effects of Metoclopramide: Associations With Clinical, Demographic, and Pharmacogenetic Parameters

  2012cites this paper
• Metabolic monosaccharides altered cell responses to anticancer drugs.

  2012cites this paper
• Moxidectin and the avermectins: Consanguinity but not identity.

  2012cites this paper
• P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.

  2012cites this paper
• Tunicamycin Depresses P-Glycoprotein Glycosylation Without an Effect on Its Membrane Localization and Drug Efflux Activity in L1210 Cells

  2011cites this paper
• Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin.

  2011cites this paper
• ELIISA MANNERMAA In vitro Model of Retinal Pigment Epithelium for Use in Drug Delivery

  2010cites this paper
• Drug penetration model of vinblastine-treated Caco-2 cultures.

  2010cites this paper
• Evaluation of drug transporter interactions in drug discovery and development.

  2010cites this paper
• Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2).

  2010cites this paper
• The Use of In Vitro Unbound Drug Fraction and Permeability in Predicting Central Nervous System Drug Penetration

  2010cites this paper
• Effluxing ABC transporters in human corneal epithelium.

  2010cites this paper
• Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine.

  2009cites this paper
• A fluorescence-based in vitro assay for drug interactions with breast cancer resistance protein (BCRP, ABCG2).

  2009cites this paper
• Unique pharmacology of KAR-2, a potential anti-cancer agent: absorption modelling and selective mitotic spindle targeting.

  2009cites this paper
• Gold-layered calcium phosphate plasmonic resonants for localized photothermal treatment of human epithelial cancer

  2009cites this paper
• The Caco-2 cell line in studies of drug metabolism and efflux

  2009cites this paper
• Inhibition of P‐glycoprotein function by procyanidine on blood–brain barrier

  2009cites this paper
• Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs.

  2009cites this paper
• In vitro effects of Mangifera indica and polyphenols derived on ABCB1/P-glycoprotein activity.

  2009cites this paper
• A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein.

  2009cites this paper
• Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis.

  2009cites this paper
• Advancement of Structure-Activity Relationship of Multidrug Resistance-Associated Protein 2 Interactions

  2009cites this paper
• Progress in the development of early diagnosis and a drug with unique pharmacology to improve cancer therapy

  2008cites this paper
• Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system.

  2008cites this paper
• The Expression of Most Udp-glucuronosyltransferases (ugts) Is Increased Significantly during Caco-2 Cell Differentiation, While Ugt1a6 Is Highly Expressed Also in Undifferentiated Cells Dmd #22335 2 Running Title: Cell Differentiation and Ugts Expression in Caco-2 Caco-2 (wild Type) Cells Obtained f

  2008cites this paper
• Ketoconazole and the modulation of multidrug resistance-mediated transport in Caco-2 and MDCKII-MDR1 drug transport models

  2008cites this paper
• The Expression of Most UDP-Glucuronosyltransferases (UGTs) Is Increased Significantly during Caco-2 Cell Differentiation, whereas UGT1A6 Is Highly Expressed Also in Undifferentiated Cells

  2008cites this paper
• Kidney proximal human tubule HK-2 cell line as a tool for the investigation of P-glycoprotein modulation by natural compounds

  2008cites this paper
• The Blood‐Brain Barrier: Roles of the Multidrug Resistance Transporter P‐Glycoprotein

  2007cites this paper
• Bioactive lignans from Peperomia duclouxii.

  2007cites this paper
• Characterization of P-glycoprotein and multidrug resistance proteins in rat kidney and intestinal cell lines.

  2007cites this paper
• Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship.

  2007cites this paper
• Bioactive pregnanes from Nerium oleander.

  2007cites this paper
• Bioactive polyketides from Peperomia duclouxii.

  2007cites this paper
• Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines.

  2007cites this paper
• LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance.

  2006cites this paper
• Membrane transporter proteins: a challenge for CNS drug development

  2006cites this paper
• L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein.

  2006cites this paper
• Caco-2 cell cultures in the assessment of intestinal absorption: Effects of some co-administered drugs and natural compounds in biological matrices

  2006cites this paper
• Metabolic and Efflux Properties of Caco-2 Cells Stably Transfected with Nuclear Receptors

  2006cites this paper
• A new taxoid from a callus culture of Taxus cuspidata as an MDR reversal agent.

  2006cites this paper
• Bioactive dibenzylbutyrolactone and dibenzylbutanediol lignans from Peperomia duclouxii.

  2006cites this paper
• Rapid assessment of p-glycoprotein-drug interactions at the blood-brain barrier.

  2006cites this paper
• Bioactive secolignans from Peperomia dindygulensis.

  2006cites this paper
• Intestinal expression of P‐glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate–glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans

  2006cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 41 Drug Transport and Metabolism in Rat and Human Intestine

  2006cites this paper
• REVIEW ARTICLE: APPLICATION OF CELL-BASED ASSAY SYSTEMS FOR THE EARLY SCREENING OF HUMAN DRUG HEPATOTOXICITY IN THE DISCOVERY PHASE OF DRUG DEVELOPMENT

  2005cites this paper
• Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.

  2005cites this paper
• P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.

  2005cites this paper
• Prediction of oral drug absorption in humans by theoretical passive absorption model.

  2005cites this paper
• Expression of P-glycoprotein in L1210 cells is linked with rise in sensitivity to Ca2+.

  2005cites this paper
• Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM

  2005cites this paper
• Bioactive tetrahydrofuran lignans from Peperomia dindygulensis.

  2005cites this paper
• Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines.

  2005cites this paper
• Prediction of Pgp–ATPase interaction and rhodamine 123 efflux inhibitory activities of propafenone analogs using PLS statistics

  2005cites this paper
• Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core.

  2005cites this paper
• Comparison of the Usefulness of the MTT, ATP, and Calcein Assays to Predict the Potency of Cytotoxic Agents in Various Human Cancer Cell Lines

  2004cites this paper
• Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models.

  2004cites this paper
• Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential.

  2004cites this paper
• Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes

  2004cites this paper
• Development of a matrix-in-cylinder system for sustained zero-order drug release

  2004cites this paper